Adrienne Scheck

Summary

Affiliation: Barrow Neurological Institute
Country: USA

Publications

  1. ncbi request reprint Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas
    Markus Bredel
    Division of Oncology, Center for Clinical Sciences Research, Institute for Computational and Mathematical Engineering, Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305 5151, USA
    J Clin Oncol 24:274-87. 2006
  2. ncbi request reprint Emerging evidence of hepatitis C virus neuroinvasion
    Tomasz Laskus
    Department of Medicine, Mayo Clinic Scottsdale, Scottsdale, Arizona 85259, USA
    AIDS 19:S140-4. 2005
  3. doi request reprint The ketogenic diet for the treatment of glioma: insights from genetic profiling
    Adrienne C Scheck
    Neuro Oncology Research, Barrow Neurological Institute of St Joseph s Hospital and Medical Center, 350W Thomas Rd, Phoenix, AZ 85013, USA
    Epilepsy Res 100:327-37. 2012
  4. pmc Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea
    Nicole C Hank
    Neuro Oncology Research, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, Phoenix, AZ 85013, USA
    BMC Cancer 6:2. 2006
  5. pmc The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma
    Phillip Stafford
    Neuro Oncology Research, Barrow Neurological Institute7 of St, Joseph s Hospital and Medical Center, Phoenix, AZ, 85013, USA
    Nutr Metab (Lond) 7:74. 2010
  6. pmc Anticancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cells
    Adrienne C Scheck
    Neuro Oncology Research, Barrow Neurological Institute of St Joseph s Hospital and Medical Center, Phoenix, AZ 85013, USA
    BMC Complement Altern Med 6:27. 2006
  7. doi request reprint Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblas
    Kris A Smith
    Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona, USA
    J Neurosurg 109:106-17. 2008
  8. ncbi request reprint Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue
    Wolfgang K Pfisterer
    Neurosurgery Research, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, Phoenix, AZ 85013, USA
    J Neurooncol 87:43-50. 2008
  9. doi request reprint Miniaturized handheld confocal microscopy for neurosurgery: results in an experimental glioblastoma model
    Tejas Sankar
    Division of Neurological Surgery, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, Phoenix, Arizona 85013, USA
    Neurosurgery 66:410-7; discussion 417-8. 2010
  10. ncbi request reprint Molecular biological determinants of meningioma progression and aggressive behavior
    Adrienne C Scheck
    Division of Neuro Oncology and Neurosurgery Research, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, 350 W Thomas Road, Phoenix, Arizona 85013, USA
    Front Biosci (Elite Ed) 1:390-414. 2009

Research Grants

  1. GLIOMA HETEROGENEITY AND CHEMOSENSITIVITY
    Adrienne Scheck; Fiscal Year: 2002

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas
    Markus Bredel
    Division of Oncology, Center for Clinical Sciences Research, Institute for Computational and Mathematical Engineering, Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305 5151, USA
    J Clin Oncol 24:274-87. 2006
    ..Pre-existing and acquired drug resistance are major obstacles to the successful treatment of glioblastomas...
  2. ncbi request reprint Emerging evidence of hepatitis C virus neuroinvasion
    Tomasz Laskus
    Department of Medicine, Mayo Clinic Scottsdale, Scottsdale, Arizona 85259, USA
    AIDS 19:S140-4. 2005
    ..However, despite some similarities there is a fundamental difference between HIV-1 and HCV infection as the latter does not progress into AIDS-type dementia...
  3. doi request reprint The ketogenic diet for the treatment of glioma: insights from genetic profiling
    Adrienne C Scheck
    Neuro Oncology Research, Barrow Neurological Institute of St Joseph s Hospital and Medical Center, 350W Thomas Rd, Phoenix, AZ 85013, USA
    Epilepsy Res 100:327-37. 2012
    ....
  4. pmc Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea
    Nicole C Hank
    Neuro Oncology Research, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, Phoenix, AZ 85013, USA
    BMC Cancer 6:2. 2006
    ..While cells from untreated gliomas often have over-representation of chromosome 7, chromosome 22 is typically under-represented...
  5. pmc The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma
    Phillip Stafford
    Neuro Oncology Research, Barrow Neurological Institute7 of St, Joseph s Hospital and Medical Center, Phoenix, AZ, 85013, USA
    Nutr Metab (Lond) 7:74. 2010
    ....
  6. pmc Anticancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cells
    Adrienne C Scheck
    Neuro Oncology Research, Barrow Neurological Institute of St Joseph s Hospital and Medical Center, Phoenix, AZ 85013, USA
    BMC Complement Altern Med 6:27. 2006
    ..We assessed the ability of an ethanolic extract of S. baicalensis root to inhibit the proliferation of malignant glioma cells...
  7. doi request reprint Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblas
    Kris A Smith
    Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona, USA
    J Neurosurg 109:106-17. 2008
    ....
  8. ncbi request reprint Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue
    Wolfgang K Pfisterer
    Neurosurgery Research, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, Phoenix, AZ 85013, USA
    J Neurooncol 87:43-50. 2008
    ..001), and with tumor recurrence (p < 0.01). The findings suggest that adding FISH analysis may allow better prediction of possible meningioma recurrence and may be a useful adjunct for therapy decisions...
  9. doi request reprint Miniaturized handheld confocal microscopy for neurosurgery: results in an experimental glioblastoma model
    Tejas Sankar
    Division of Neurological Surgery, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, Phoenix, Arizona 85013, USA
    Neurosurgery 66:410-7; discussion 417-8. 2010
    ..Clinical confocal imaging applications have emerged, including assessment of colonic mucosal dysplasia during colonoscopy. We present our initial experience with handheld, miniaturized confocal imaging in a murine brain tumor model...
  10. ncbi request reprint Molecular biological determinants of meningioma progression and aggressive behavior
    Adrienne C Scheck
    Division of Neuro Oncology and Neurosurgery Research, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, 350 W Thomas Road, Phoenix, Arizona 85013, USA
    Front Biosci (Elite Ed) 1:390-414. 2009
    ..The identification of a marker of aggressive behavior would allow the development of improved clinical protocols based on early intervention for those patients likely to experience a recurrence...
  11. ncbi request reprint Fluorescent in situ hybridization and ex vivo 1H magnetic resonance spectroscopic examinations of meningioma tumor tissue: is it possible to identify a clinically-aggressive subset of benign meningiomas?
    Wolfgang K Pfisterer
    Neurosurgery and Neuro Oncology Research, Barrow Neurological Institute, St Joseph s Hospital and Medical Center, Phoenix, Arizona 85013, USA
    Neurosurgery 61:1048-59; discussion 1060-1. 2007
    ....
  12. pmc Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas
    Wolfgang K Pfisterer
    Neuro Oncology Research and Neurosurgery Research Laboratory, Barrow Neurological Institute of St Joseph s Hospital and Medical Center, Phoenix, AZ 85013, USA
    Neuro Oncol 6:290-9. 2004
    ..05). We conclude that the appearance of chromosomal aberrations in different areas of the tumor demonstrates the importance of regional heterogeneity in the biological behavior of meningiomas...

Research Grants5

  1. GLIOMA HETEROGENEITY AND CHEMOSENSITIVITY
    Adrienne Scheck; Fiscal Year: 2002
    ..The clinical significance of these findings will be validated in fresh frozen and paraffin embedded samples by analyzing tissue from their extensive tumor bank (Specific Aim 4). ..